A214260 Stock Overview
Provides skin-based drug delivery systems in South Korea, Japan, and China. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Raphas Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩14,880.00 |
| 52 Week High | ₩31,500.00 |
| 52 Week Low | ₩9,300.00 |
| Beta | 1.5 |
| 1 Month Change | 9.25% |
| 3 Month Change | -31.90% |
| 1 Year Change | -22.74% |
| 3 Year Change | -66.90% |
| 5 Year Change | -19.35% |
| Change since IPO | -17.56% |
Recent News & Updates
Is Raphas (KOSDAQ:214260) Using Too Much Debt?
Oct 11
Investors Appear Satisfied With Raphas Co., Ltd.'s (KOSDAQ:214260) Prospects As Shares Rocket 28%
Aug 12Raphas Co., Ltd.'s (KOSDAQ:214260) 27% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio
Jun 25Does Raphas (KOSDAQ:214260) Have A Healthy Balance Sheet?
Jun 20Recent updates
Is Raphas (KOSDAQ:214260) Using Too Much Debt?
Oct 11Investors Appear Satisfied With Raphas Co., Ltd.'s (KOSDAQ:214260) Prospects As Shares Rocket 28%
Aug 12Raphas Co., Ltd.'s (KOSDAQ:214260) 27% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio
Jun 25Does Raphas (KOSDAQ:214260) Have A Healthy Balance Sheet?
Jun 20What Type Of Shareholders Make Up Raphas Co., Ltd.'s (KOSDAQ:214260) Share Registry?
Feb 17
Does Raphas (KOSDAQ:214260) Have A Healthy Balance Sheet?
Jan 12Investors Who Bought Raphas (KOSDAQ:214260) Shares A Year Ago Are Now Up 64%
Dec 08Shareholder Returns
| A214260 | KR Personal Products | KR Market | |
|---|---|---|---|
| 7D | -7.9% | -2.3% | -1.6% |
| 1Y | -22.7% | -10.8% | -9.1% |
Return vs Industry: A214260 underperformed the KR Personal Products industry which returned -11% over the past year.
Return vs Market: A214260 underperformed the KR Market which returned -7.7% over the past year.
Price Volatility
| A214260 volatility | |
|---|---|
| A214260 Average Weekly Movement | 12.8% |
| Personal Products Industry Average Movement | 7.5% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in KR Market | 12.6% |
| 10% least volatile stocks in KR Market | 3.3% |
Stable Share Price: A214260's share price has been volatile over the past 3 months compared to the KR market.
Volatility Over Time: A214260's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 77 | Dohyeon Jeong | www.raphas.co.kr |
Raphas Co., Ltd. provides skin-based drug delivery systems in South Korea, Japan, and China. The company offers cosmetics under the Acropass brand. It also provides original design manufacturer services in producing cosmetics for various needs, such as wrinkle reduction, freckle, and acne treatment; and medical contract manufacturing services.
Raphas Co., Ltd. Fundamentals Summary
| A214260 fundamental statistics | |
|---|---|
| Market cap | ₩125.12b |
| Earnings (TTM) | -₩11.44b |
| Revenue (TTM) | ₩28.38b |
4.4x
P/S Ratio-10.9x
P/E RatioIs A214260 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A214260 income statement (TTM) | |
|---|---|
| Revenue | ₩28.38b |
| Cost of Revenue | ₩16.06b |
| Gross Profit | ₩12.32b |
| Other Expenses | ₩23.76b |
| Earnings | -₩11.44b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.36k |
| Gross Margin | 43.41% |
| Net Profit Margin | -40.29% |
| Debt/Equity Ratio | 111.2% |
How did A214260 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/19 06:04 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Raphas Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|